Singapore-headquartered Qritive has integrated its AI modules with US-based Corista's image management platform DP3.
According to a press statement, the combined solution leverages AI to screen for both prostate and colon cancers, quantify IHC markers, and detect lymph node metastasis.
It allows pathologists to prioritise and grade specific cases while improving the detection of hard-to-...
